Anixa Biosciences
ANIX
ANIX
49 hedge funds and large institutions have $12.8M invested in Anixa Biosciences in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.87% more ownership
Funds ownership: 11.77% → 12.64% (+0.87%)
60% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 15
Holders
49
Holding in Top 10
–
Calls
$205K
Puts
$1K
Top Buyers
| 1 | +$1.64M | |
| 2 | +$49K | |
| 3 | +$44.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$41.2K |
| 5 |
LPL Financial
San Diego,
California
|
+$17.2K |
Top Sellers
| 1 | -$294K | |
| 2 | -$163K | |
| 3 | -$160K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$97.6K |
| 5 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$55.7K |